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Abstract
Purpose: Kidney failure influences the treatment outcomes of abdominal aortic aneurysm (AAA). A prospective study 
of renal function before and after aortic stent-graft treatment was performed. Special attention was paid to the influence 
of preoperative kidney function as well as the impact of the radiological follow-up.
Material and methods: A total of 214 endovascularly treated AAA patients were included. In all cases, pre- and postope-
rative estimated glomerular filtration rate (eGFR) and serum creatinine were noted. Patients were prospectively fol-
lowed up for a minimum of two years.
Results: The baseline eGFR was 69.38 ± 16.29 ml/min/1.73 m2. Chronic kidney disease at baseline was noted in 29% 
of patients. In the direct postoperative period, acute kidney injury was identified in 8.4% of cases. Additional endo-
vascular procedures within two years of observation were performed in 5.6% of cases, and over the two years of 
follow-up, in the study group from one to six angio-computed tomographic scans (angio-CT) per patient were per-
formed. The mean eGFR value after the 24-month follow-up was significantly lower than the preoperative value. 
Among the factors influencing kidney function, an angio-CT during the same hospital stay of the primary stent-graft 
procedures was identified. The type of stent-graft, contrast volume during the primary procedure, need for reinter-
vention, concomitant disease presence, and statin use did not show statistical significance.
Conclusions: Angio-CT followed by stent-graft implantation over a short time interval (within the same hospitalisation) 
significantly worsened renal function in the late follow-up and should be avoided in elective AAA cases.
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Introduction
The risk of contrast-induced nephropathy, as well as renal 
function worsening, is an important consequence of intra-
venous or intra-arterial contrast administration during dia-
gnostic and therapeutic procedures [1-3]. A growing num-
ber of minimally invasive endovascular procedures and 
contrast-enhanced computed tomography (CTs), together 
with the aging population and the increasing number of 
diabetic patients, has resulted in large numbers of patients 
being at risk of renal failure development as well as renal 
function deterioration [1,2,4-6].
Among this very special group, in the aspect of the re-
nal function evaluation and follow-up, are patients with the 
abdominal aortic aneurysm (AAA), who are qualified to 
endovascular aneurysm treatment. In this clinical scenario, 
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proper renal function has a great influence on the clini-
cal outcome and the long-term results [6-8]. Exposure of 
the vascular patient with renal function impairment to 
contrast medium during the aortic stent-graft implanta-
tion procedures potentially worsens final outcomes and 
increases the risk of renal function deterioration (in par-
ticular, if the postoperative follow-up is based on repeated 
angio-CT examinations).
However, renal function impairment is also important 
in open vascular reconstruction procedures; according to 
the literature, renal failure is a significant factor related 
to mortality and morbidity associated with open surgery 
for AAA [9-11]. Despite the lack of exposure to con-
trast medium, open AAA surgery seems to be related to 
a much higher acute renal failure rate than endovascular 
aneurysm repair [8-11]. Comparing the two methods of 
AAA treatment, Wald et al. analysed the clinical courses 
of a total of 6516 patients undergoing open or endovas-
cular elective repairs. Endovascular aortic repair (EVAR) 
procedures were associated with lower odds of acute renal 
failure and acute renal failure requiring dialysis than in 
open surgery patients (in this study, all patients with ini-
tial end-stage renal disease were excluded, and the rate of 
the postoperative renal failure was 6.7% in the total popu-
lation) [12]. Al Adas et al. suggested that open aneurysm 
repair was related to a 1.6 times greater likelihood of the 
development of immediate postoperative acute kidney in-
jury, compared with EVAR. In another study, Tang et al. 
noted a 29% rate of acute renal failure after open surgery, 
Bang et al. suggested a rate of 18.8% of this complication, 
and Dariane et al. reported 24% [9,11,13]. 
In both groups (open AAA surgery or EVAR), the 
presence of the preoperative renal function deterioration 
can significantly influence the treatment outcomes and 
represents an important factor related to a greater pos-
sibility of renal failure development in the post-operative 
period [11,14]. Another significant factor related to the 
risk of renal function worsening is further exposure to 
contrast medium, which is potentially important in the 
group of patients requiring follow-up studies based on 
contrast CT examinations (now an important component 
of the follow-up protocol in many medical centres) [11]. 
In this paper, a prospective assessment of renal function 
before and after endovascular treatment was performed. 
Special attention was paid to the influence of the preopera-
tive kidney functional status, as well as of follow-up studies, 
on long-term proper renal function maintenance.
Material and methods
A group of 214 patients with AAA was evaluated. All of 
the patients were qualified for abdominal aortic stent-graft 
placement. There were 178 men and 36 women. The medi-
an age in the male population was 73 years (range 58-92) 
and 72 years in the female population (range 54-85). 
The size of the AAA ranged from 44 to 107 mm, and in 
the study, only non-ruptured AAA patients were evaluated. 
In 134 cases stent-grafts with suprarenal fixation (Zenith; 
COOK) were used, and in the other 80 cases an infrarenal 
fixation (Excluder, GORE) was applied; the choice of the 
aortic stent-graft was based on the vessel anatomy. In 70% 
of the patients, arterial hypertension was present, and in 
61.6%, ischaemic heart disease was previously diagnosed 
(including 66 patients after previous heart infarction). 
In the study population, 10.2% suffered from atrial fibril-
lation, in 10.2% heart valve disease was noted, in 9.3% dia-
betes was recognised, and in 6.5% stroke in the past was 
reported. Of the patients, 10.2% suffered from chronic re-
spiratory diseases, and in 2.3% gastroduodenal ulcer his-
tory was present. The median body mass index (BMI) in 
the female population was 27.14 (range 19.93-34.6), and in 
the male population it was 27.43 (range 14.53-40.74). Two 
patients died perioperatively and were excluded from the 
study; in both cases, no acute renal failure after surgery was 
observed, and the reasons for death were heart infarction 
and circulatory failure. In all of the patients, preoperative 
kidney function evaluation, based on estimated glomerular 
filtration rate (eGFR) and serum crea tinine, was performed. 
Patients with renal artery stenosis, as well as end-stage re-
nal disease, were excluded from the study. Another exclu-
sion criterion was unilateral or bilateral kidney hypoplasia 
or aplasia. In all of the patients, during the evaluation and 
qualification process, angio-CT examination was performed 
preoperatively. Before stent graft implantation, in all pa-
tients of the study group, which fulfil AAA treatment cri-
teria (symptomatic aneurysm, fast aneurysm growth, size 
> 5.5 cm), a CT angiogram examination was performed 
with an assessment of the abdominal aorta, iliac arteries, 
and access vessels. In the qualification process the anatomi-
cal criteria as well as the risk of surgery complications were 
taken into consideration, and all of the patients underwent 
cardiological consultation before the final decision. In the 
patients with severe renal function impairment a nephro-
logical consultation was always requested. According to 
the renal protection protocol in our centre, in the patents 
with primary known renal function impairment, the spe-
cial preparation before contrast administration during dia-
gnostic (e.g. angio-CT) and therapeutic procedures were 
implemented. The protocol was based in the periprocedural 
hydration with crystalloids (1 ml/kg/h) 12 hours before and 
12-24 hours after the procedure, the use of N-acetylcyste-
ine, 1200 mg twice a day, and suspension of all potentially 
nephrotoxic drugs (including non-steroid anti-inflamma-
tory drugs). The protocol was supported by daily creatinine 
and diuresis monitoring as well as periprocedural hypoten-
sion treatment and multiple procedure avoidance. 
In 125 of the patients (58.5%), the CT angiogram was 
performed before hospitalisation (at least two weeks before) 
and in 89 patients (41.5%) during the same hospitalisation 
(after admission to the hospital) but before stent-graft im-
plantation. Concerning the patients undergoing CT angio-
gram examination during the same hospitalisation (includ-
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ing treatment procedure) the mean time interval between 
the CT and procedure was 3.6 days in the range from one 
to nine days. In all cases, the stent-graft implantations were 
performed under fluoroscopy with the contrast administra-
tion according to the standard protocol. Non-ionic contrast 
was used, and the volume of contrast used was recorded. All 
of the patients received dual antiplatelet therapy periopera-
tively and six weeks after, followed by lifelong aspirin admin-
istration. In 70% of the patients, statins were administered 
(because of concomitant disease presence): atorvastatin, 
simvastatin, and rosuvastatin were used. After the procedure 
(no perioperative deaths were reported), the presence of 
perioperative acute renal failure, defined as an increase of 
≥ 50% and/or ≥ 0.3 mg/dl from preprocedural serum crea-
tinine over 48 hours postoperatively, was reported [15,16].  
Patients were followed up in the outpatient department; 
the follow-up was based on repeated US and angio-CT con-
trol. Angio-CT was routinely performed three months after 
the procedure, and the decision concerning the next follow-
up CT was based on the three-month CT results, including 
aneurysm sack shrinking or expansion, as well as potential 
endoleak presence or suspicion (type II mostly). In some 
of the obese patients, the need for a CT-based approach 
was related to the lack of the proper aorta visibility on US 
examination during the subsequent follow-up examina-
tion. All of the patients were prospectively followed up for 
a minimum of two years, according to the standard proto-
col, and the number of contrast CT examinations and the 
number of patients requiring reintervention was recorded. 
In all of the patients, eGFR value after 24 months of follow-
up was noted, and factor analysis influencing potential 
kidney function worsening was performed. During the last 
follow-up visit in the study (24 months after stent-graft im-
plantation), US examination of both kidneys with kidney 
size measurements (B-mode) was performed.
In this analysis, preoperative kidney function was evalu-
ated, including the preoperative presence of chronic renal 
failure. Other studied factors were the volume of contrast 
administered during the primary stent-graft procedure, the 
performance of angio CT during the same hospitalisation as 
the stent-graft procedure, the number of angio-CT procedures 
performed during the follow-up phase, the type of stent-graft 
fixation (suprarenal or subrenal), the need for reintervention, 
the presence of concomitant disease, the use of statins in the 
perioperative period, and the long-term treatment. 
In the statistical analysis, the Statistica software, version 
13.1, was used. The statistical tests were the t-test and Spear-
man’s correlation, and for the evaluation of the importance 
of several risk factors to the final eGFR levels, ANOVA uni-
variate analysis was performed. The results were considered 
significant with p < 0.05. 
Results
In the analysed cohort, the baseline creatinine level was 
1.05 ± 0.28 mg/dl. The baseline eGFR was 69.38 ± 16.29 ml/ 
min/1.73 m2. Chronic kidney disease, defined as eGFR 
≤ 60 ml/min/1.73 m2 at baseline, was noted in 29% of the 
patients. In the early postoperative period during the hospi-
tal stay, acute kidney injury was identified in 8.4% of cases, 
and all of the patients were treated conservatively without 
the need for dialysis during the hospital stay. In none of 
these patients was coverage of one or both renal arteries 
noted. In the follow-up period, one patient required dialy-
sis due to renal function worsening in the late follow-up 
phase; this patient had already presented with chronic kid-
ney failure before the primary procedure (without acute 
kidney injury during postoperative hospital stay). Over 
the 24-month follow-up period, from one to six angio-CT 
examinations were performed on each patient. The need 
for additional endovascular procedures within two years of 
follow-up was noted in 5.6% of cases. The mean eGFR val-
ue after 24 months of follow-up was 62.09 ± 18.5 ml/min/ 
1.73 m2 and was significantly lower than preoperatively 
(Figure 1). The worsening of the glomerular filtration rate 
involved not only the patients with primary present chronic 
kidney failure (eGFR ≤ 60 ml/min/1.73 m2) but also patients 
with normal renal function preoperatively (Figure 2A-B). 
In the statistical analysis, we did not find a relationship 
between the presence of concomitant diseases, including 
arterial hypertension, ischaemic heart disease, and diabe-
tes, and worsening of renal function (ANOVA univariate). 
Additionally, the type of implanted stent-graft (infra-renal 
or supra-renal fixation) did not influence renal function 
worsening. The use of statin treatment perioperatively, as 
well as during long-term follow-up, did not significantly 
influence GFR changes between the statin and no-statin 
groups. There were also no correlations between the initial 
procedure (stent-graft placement), contrast medium vol-
ume, and final eGFR value. Concerning other exposures 
to contrast medium, the performance of the angio-CT 
examination followed by stent-graft placement during the 
Figure 1. Estimated glomerular filtration before stent-graft implantation 
and after 2 years of follow-up in the whole group of abdominal aortic 
aneurysm patients (p = 0.000001, t-test)
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same hospitalisation turned out to be a factor of statistical 
importance in both the chronic renal failure (Figure 3A) 
and no chronic renal failure (Figure 3B) groups. 
As previously mentioned, in all of the patients, CT 
angiography was performed at least once postoperatively 
(three months after the procedure). The number of the 
CT angiograms ranged from one to six. Looking for the 
correlation between the number of CT angiogram proce-
dures performed and the differences between the initial 
and 24-month follow-up eGFR, no statistically significant 
relationship was observed (Figure 4). One important ex-
planation for this fact could be an observation concern-
ing the reduced number of CT examinations in patients 
with initial renal failure (Figure 5); in this patient group, 
in the later phase of the follow-up, the CTs were supple-
mented by ultrasound examination (if no clinical need 
for a CT-based approach was noted). In the patients with-
out initial renal failure, there was no correlation between 
the number of CTs and the eGFR value. 
The performance of an additional endovascular pro-
cedure over the two-year follow-up period (12 patients 
required reintervention – 5.6%) did not influence the final 
eGFR value after 24 months of follow-up. 
When analysing the kidney morphological criteria (as-
sessed at the 24-month follow-up visit), the correlation 
between the kidney length and 24-month follow-up eGFR 
was observed only in patients with initially normal renal 
function (Figure 6). In patients with chronic renal failure, 
such observations were not confirmed at the last follow-up 
visit – the size of the kidney did not correlate with the eGFR 
value in the patients with impairment of renal function at 
the beginning of the study. 
Figure 2. Estimated glomerular filtration (eGFR) before stent-graft implantation and after 2 years of follow-up in patients with chronic renal failure (A) 
(GFR ≤ 60 ml/min/1.73 m2) preoperatively (p < 0.005) or without chronic renal failure (B) (GFR > 60 ml/min/1.73 m2) (p = 0.000001), t-test evaluation
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Figure 3. Estimated glomerular filtration (eGFR) before stent-graft implantation and after 2 years of follow-up in the patients with renal failure (A) (GFR 
≤ 60 ml/min/1.73 m2) and angio-computed tomography (CT) performed before stent-graft placement during the same hospitalisation (p = 0.000012, 
t-test); B) eGFR before stent-graft implantation and after 2 years of follow-up in the patients with no renal failure (GFR > 60 ml/min/1.73 m2) and CT 
angiogram performed before stent-graft placement during the same hospitalisation (p = 0.0002, t-test)
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Discussion 
Development of minimally invasive procedures in vascular 
surgery, as well as common use of diagnostic procedures 
with contrast medium, has made renal function mainte-
nance a significant problem in contemporary medicine. In 
the analysed cohort, according to the initial pre-procedural 
assessment, the rate of impaired renal function was 29%, 
and in the majority of the patients, significant comorbidi-
ties were present. Over the two-year follow-up period, a de-
crease in eGFR was observed in the renal failure group, as 
well as in the normal renal function group. This outcome 
suggests the risk of renal function deterioration also in pa-
tients without previous renal function deterioration. 
Looking at the peri- and postoperative renal function 
worsening in vascular patients, acute kidney injury, as well 
as chronic renal failure, should be mentioned. The litera-
ture has described the rate of acute renal failure related to 
contrast administration as 1-13%, depending on the treated 
population [1-4]. Despite development of new contrast me-
dia, the number of kidney complications remains relatively 
high, and deterioration of renal function after contrast-
based radiological or endovascular procedures must be 
considered. Another problem related to contrast adminis-
tration is CT angiogram follow-up studies, as well as re-
performance of procedures. Although acute renal injury is 
less likely to occur after endovascular aneurysm treatment, 
the EVAR procedure and postoperative follow-up of stent-
graft patients can lead to significant, often delayed wors-
ening of renal function [11]. In terms of the postoperative 
mortality and morbidity, in the long-term follow-up, not 
only potential endoleak presence but also renal function 
should be monitored. 
Among the known risk factors for acute renal failure 
in patients undergoing contrast administration are dehy-
dration, diabetes, concomitant medical treatment with 
metformin, ACE inhibitors, non-steroidal anti-inflamma-
tory drugs, and certain antibiotics [17-21]. In AAA pa-
tients treated endovascularly, haemodynamic instability, 
blood transfusions, poor cardiac reserve, duration of the 
procedure, as well as the contrast volume used, and previ-
ous renal failure should also be mentioned [9,11,12,23].
Looking for factors responsible for acute renal failure 
defined in our population as creatinine level increase of 
0.3 mg/dl or 50% creatinine increase from the initial val-
ue within 48 hours of the procedure, we did not find any 
significant ones except for 65% of these cases occurring in 
patients with previous renal function impairment. The type 
of implanted stent graft, contrast volume used, concomitant 
disease presence, and medication used did not influence 
AKI frequency in our study; however, as mentioned in the 
material description, patients with end-stage renal disease 
were excluded from the study. None of the treated patients 
required dialysis due to AKI during hospitalisation. 
Chronic renal failure progression seems to be even 
more difficult to avoid in patients exposed to contrast me-
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Figure 4. Estimated glomerular filtration rate (eGFR) difference between 
pre operative eGFR value and 24-month follow-up eGFR assessment in 
relationship to the number of angio-computed tomography procedures 
performed in the follow-up phase (p > 0.05) 
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Figure 5. The number of computed tomography scans performed after 
stent-graft implantation in patients with initial renal failure and estimat-
ed glomerular filtration after 24 months of follow-up (p > 0.05, r = 0.2, 
Spearman’s correlation)
Figure 6. Estimated glomerular filtration after 24 months of follow-up 
and length of kidneys in patients without initial renal failure (p = 0.03, 
r = 0.19, Spearman’s correlation)
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dium if repeated procedures are needed [11]. In our cohort, 
in both groups with and without previous renal function 
impairment, continuous eGFR decrease was noted. Seek-
ing the most significant factor, angio-CT examinations 
followed by stent-graft placement during the same (initial) 
hospitalisation were critical. This important observation 
concerned both groups with and without renal failure. In 
light of this finding, in patients qualified for AAA elective 
endovascular treatment, preoperative angio-CT should be 
planned before the admission dedicated to stent-graft im-
plantation. The time interval between the CT angiogram 
examination and procedure performance in both groups 
(with and without renal failure) should be planned. 
The presence of concomitant diseases, including dia-
betes (present in our cohort only in 10.2%), statin use, re-
performance of procedures, the type of stent-graft (infra- 
or suprarenal fixation), and primary procedure contrast 
volume, did not show statistical significance in terms of 
chronic renal failure development. In the follow-up period, 
at least one CT angiogram was performed in each patient 
(the number of CT studies within 24 months of follow-up 
ranged from one to six). Repeated CT examinations did 
not influence renal failure occurrence if proper renal func-
tion was initially observed. According to the observation 
protocol, the time interval between CT studies was 6-12 
months and was shortened if endoleaks or aneurysm sack 
expansion was present. In the patients with primary in-
jured kidneys, attention was paid to the need for US-based 
follow-up, which significantly decreased the number of the 
CT examinations performed in this group after the initial 
three-month follow-up examination. 
De Bruin, in post hoc analysis of data from the DREAM 
trial (Dutch Randomised Endovascular Aneurysm Manage-
ment) found that renal function five years after open aneu-
rysm repair and EVAR for AAA did not differ between the 
two groups, and the surgical procedure did not accelerate the 
loss of renal function [24]. Brown et al. observed similar re-
sults in a study based on the UK EndoVascular Aneurysm 
trial with a 3.6-year follow-up period. In both groups (open 
and endovascular AAA repair), the renal function deteriora-
tion was slow with little evidence to suggest any long-term 
difference between treatment with EVAR or open surgery 
[25]. Other investigators did not agree with this statement. 
Al Adas, in a study based on more than 700 AAA patients, 
suggested that renal function decline in late follow-up is more 
common in patients treated with aortic stent-graft implanta-
tion [11]. Milis et al., comparing the effects of open and endo-
vascular AAA repair on long-term renal function, confirmed 
that renal function decline was significantly more common in 
the endovascular arm than after open surgery [26]. 
An interesting observation also comes from morpho-
logical kidney assessment. In the reported material, there 
was no correlation between the size of the kidneys and 
24-month eGFR value in patients with initial renal failure, 
suggesting the limited value of the kidney morphology 
evaluation (and its changes) in patients with renal function 
impairment according to laboratory assessment. In contrast 
to this observation, the reduction in the kidney size of the 
patients with primary proper renal function was a potential 
marker for renal function impairment and should be moni-
tored during follow-up studies because it has the potential 
to select patients at risk of chronic renal failure if repeated 
contrast studies are performed. 
Conclusions
In patients qualified for abdominal aortic endovascular 
treatment, especially those with chronic renal failure, precise 
renal function assessment, as well as renal function protec-
tion, should always be considered. Angio-CT followed by 
stent-graft implantation in a short time interval (within the 
same hospitalisation) significantly decreased renal function 
in late follow-up and should be avoided in elective AAA 
cases.
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